Clinical trial Recruiting at 1 site Interventional Ages 60 to 85

mGlide-Care: Partnering with Caregivers to Manage High Blood Pressure

Official title: mGlide-Care: A Partnership With Caregivers to Improve HTN Management in Patients With Cognitive Impairment

Run by University of Minnesota · NCT05850416 · Data updated 2026-11-12

This project will test a smartphone-based blood pressure program, mGlide-Care, to help people with mild cognitive impairment or early Alzheimer's disease and their unpaid family caregivers improve control of high blood pressure.

More Hypertension (HTN) trials

Quick facts

Study typeInterventional
Ages60 Years to 85 Years
SexAll
Enrollment75 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedMay 30, 2028
Study endsMay 30, 2028
Registry record updatedFebruary 13, 2026
Trial IDNCT05850416 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults with early-stage AD/ADRD or MCI who have uncontrolled hypertension, an established HTN diagnosis, an unpaid family caregiver willing to assist, and access to a smartphone or tablet that can transmit blood pressure readings.

Probably not a fit

Patients with severe life-limiting comorbid illness, active illicit drug use, homelessness or inability to complete study tasks, or those without a caregiver or compatible mobile device are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

mGlide-Care adapts an existing mHealth hypertension care model to the needs of people with early-stage AD/ADRD or MCI by explicitly involving unpaid family caregivers in home blood pressure monitoring and communication with clinical teams. In Aim 1 investigators will engage patients, caregivers, primary care providers, geriatricians, and pharmacists to refine the intervention for acceptability and usability. In Aim 2 they will run a feasibility pilot comparing mGlide-Care to usual care in 75 participants with uncontrolled hypertension, with caregivers assisting participants in using smartphone-connected BP monitors. Primary outcomes include feasibility measures and blood pressure control, collected through remote BP transmissions and routine clinical follow-up at the Minneapolis site.

Why it matters

Potential benefit: If successful, mGlide-Care could help people with early AD/MCI and their caregivers achieve better blood pressure control, which may lower risk of stroke and heart disease.

How similar studies have gone: mGlide-Care is adapted from mGlide, and mobile health programs have improved blood pressure control in other populations, but caregiver-mediated HTN management specifically in early AD/ADRD is largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Must meet all criteria

* Diagnosed with early stage AD/ADRD or MCI
* Have uncontrolled hypertension (HTN)
* Have an unpaid, family caregiver
* Have established medical diagnosis of hypertension (HTN)
* English speaking
* Participant or caregiver must have a smartphone or mobile device (e.g. iPad) that can transmit blood pressure (BP) from the BP monitor
* Participant and caregiver capable and willing to comply with the entire study protocol
* Able to give voluntary written informed consent.

Exclusion Criteria: Any of the following will be an exclusion.

* Severe comorbid illness including end-stage kidney disease, end-stage liver disease, and life expectancy \<1 year, or if medical complexity of the patient precludes clinical trial participation
* Active illicit drug use (e.g. cocaine, methamphetamines, opioids, phencyclidine) since this will interfere with HTN management
* Participant and caregiver unable to complete study tasks, including are homeless, will leave the country, or will relocate in the next 12 months
* Serious psychiatric illness that could interfere with treatment, assessment, or compliance including significant delusional disorders such as schizophrenia and bipolar illness
* Unable or unwilling to give consent.

Where it's running

  • Epidemiology Clinical Research Center
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.